ACARIZAX 6 UNIT
DERMATOPHAGOIDES FARINAE : 6 UNIT DERMATOPHAGOIDES PTERONYSSINUS : 6 UNIT · DIN 02463644 · ALK-ABELLO A/S
Health Canada status: MARKETED
What is ACARIZAX?
ACARIZAX 6 UNIT contains DERMATOPHAGOIDES FARINAE : 6 UNIT DERMATOPHAGOIDES PTERONYSSINUS : 6 UNIT. It is listed in the Health Canada Drug Product Database under DIN 02463644, held by ALK-ABELLO A/S, supplied as TABLET for SUBLINGUAL administration. Health Canada currently lists it as marketed, status dated 06-Nov-2017. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02463644 |
|---|---|
| Brand name | ACARIZAX |
| Generic / active ingredient | DERMATOPHAGOIDES FARINAE : 6 UNIT DERMATOPHAGOIDES PTERONYSSINUS : 6 UNIT |
| Manufacturer | ALK-ABELLO A/S |
| Strength | 6 UNIT |
| Dosage form | TABLET |
| Route of administration | SUBLINGUAL |
| Schedule | Prescription |
| ATC code | V01AA03 HOUSE DUST MITES |
| AHFS class | 92:05.00* ; See footnote |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 06-Nov-2017 |
| Original market date | 2017-11-06 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code V01AA03 HOUSE DUST MITES. 12 of 27 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ALLERGENIC EXTRACT - STANDARDIZED MITE DERMATOPHAGOIDES FARINAE | 10000 UNIT | LIQUID | GREER LABORATORIES INC | MARKETED | DIN 02231321 |
| ALLERGENIC EXTRACT - STANDARDIZED MITE DERMATOPHAGOIDES PTERONYSSINUS | 10000 UNIT | LIQUID | GREER LABORATORIES INC | MARKETED | DIN 02231324 |
| ALLERGENIC EXTRACT - STANDARDIZED MITE MIX | 5000 UNIT | LIQUID | GREER LABORATORIES INC | MARKETED | DIN 02231325 |
| ALLERGENIC EXTRACT MIXTURE OF STANDARDIZED MITES (5,000 AU/ML) | 5000 UNIT | SOLUTION | JUBILANT HOLLISTERSTIER LLC | MARKETED | DIN 02223996 |
| ALLERGENIC EXTRACT STANDARDIZED MITE DF (10,000 AU/ML) | 10000 UNIT | SOLUTION | JUBILANT HOLLISTERSTIER LLC | MARKETED | DIN 02223953 |
| ALLERGENIC EXTRACT STANDARDIZED MITE DF (30,000 AU/ML) | 30000 UNIT | SOLUTION | JUBILANT HOLLISTERSTIER LLC | MARKETED | DIN 02223961 |
| ALLERGENIC EXTRACT STANDARDIZED MITE DP (10,000 AU/ML) | 10000 UNIT | SOLUTION | JUBILANT HOLLISTERSTIER LLC | MARKETED | DIN 02223937 |
| ALLERGENIC EXTRACT STANDARDIZED MITE DP (30,000 AU/ML) | 30000 UNIT | SOLUTION | JUBILANT HOLLISTERSTIER LLC | MARKETED | DIN 02223945 |
| ALLERGENIC EXTRACT, STANDARDARDIZED MITE, D. FARINAE | 10000 UNIT | LIQUID | ALK-ABELLO INC | MARKETED | DIN 02217082 |
| ALLERGENIC EXTRACT, STANDARDIZED MITE MIXED | 5000 UNIT | LIQUID | ALK-ABELLO INC | MARKETED | DIN 02270919 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.